DKK3 and ovarian carcinoma: Previous in vitro studies have shown that the tumor suppressor potential of DKK3 is mediated via angiogenesis in ovarian cancer cell lines and via mitochondrial and Fas death receptor pathways in mucinous ovarian cancer cells [18,19].